MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Neurogene, Inc. Common Stock

NGNE

#2511
Neurogene, Inc. Common Stock
23.4900
+21.87%
Sector:
Base:
Profit Currency:
Daily Range
23.4900
23.4900
Year Range
15.9300
35.4700
Daily Change
+21.87%
Monthly Change
+18.04%
6 month change
-20.16%
Year Change
-20.16%
Previous Close
19.2750
Open
23.4900
Bid
Ask
Low
23.4900
High
23.4900
Volume
39
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. NGNE
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Investing Investing
C BAC-PS DELL GS-PA ORCL
yesterday, 19:01
Netflix, Dell among market cap stock movers on Friday
Benzinga Benzinga
NGNE
yesterday, 08:06
Why Is Neurogene Stock Skyrocketing Friday? - Neurogene (NASDAQ:NGNE)
Investing Investing
NGNE
2 days ago, 21:55
Neurogene stock surges 30% on FDA breakthrough therapy status
Investing Investing
NGNE
2 days ago, 21:13
FDA grants breakthrough therapy status to Neurogene’s Rett drug
Investing Investing
TSHA NGNE
2026.01.12
Stifel reiterates Buy rating on Neurogene stock, cites viable safety margin
Investing Investing
NGNE
2026.01.12
Neurogene doses multiple patients in Rett syndrome gene therapy trial
Investing Investing
NGNE TSHA
2025.12.17
Citizens reiterates Market Outperform rating on Taysha Gene Therapies stock
Seeking Alpha Seeking Alpha
INCY ABVX MDGL ALKS IMTX
2025.12.16
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Seeking Alpha Seeking Alpha
NGNE
2025.11.24
Neurogene: From Speculation To Execution With NGN-401 (NASDAQ:NGNE)
Investing Investing
NGNE TSHA
2025.11.14
Cantor Fitzgerald maintains Overweight rating on Taysha Gene Therapies stock
Investing Investing
NGNE
2025.11.13
Stifel reiterates Buy rating on Neurogene stock after positive Rett data
Investing Investing
NGNE TSHA
2025.11.13
Neurogene stock price target raised to $70 from $65 at H.C. Wainwright

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd